SCHEMBL31718481

SCHEMBL31718481

O=C(CCl)Nc1ccnc(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMARCA2 P51531 9/20 0.61
SMARCA4 P51532 8/20 0.61
GSTO1 P78417 3/20 0.47
ALDH1A1 P00352 3/20 0.46
HTT P42858 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MITF O75030 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
XBP1 P17861 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NOD2 Q9HC29 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 1/20 0.45
MAPK1 P28482 1/20 0.45
PRMT1 Q99873 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5145795 0.89 SMARCA2 (0.65) SMARCA2SMARCA4MEN1KMT2APOLB
SCHEMBL7933383 0.85 SMARCA2 (0.59) SMARCA2SMARCA4MEN1MAPTKMT2A
SCHEMBL27481922 0.82 SMARCA2 (0.57) SMARCA2SMARCA4ALDH1A1KDM4EMEN1
SCHEMBL9599834 0.82 SMARCA2 (0.86) SMARCA2SMARCA4ALDH1A1HTTNPC1
SCHEMBL22584967 0.81 AR (0.52) GSTO1ALDH1A1HTTSMN1; SMN2MITF
SCHEMBL2191563 0.81 SMARCA2 (0.60) SMARCA2SMARCA4ALDH1A1HTTSMN1; SMN2
SCHEMBL17796335 0.81 HPGD (0.58) SMARCA2SMARCA4ALDH1A1SMN1; SMN2NOD2
SCHEMBL9600748 0.81 SMARCA2 (0.63) SMARCA2SMARCA4ALDH1A1HTTKDM4E
SCHEMBL1400789 0.80 SMARCA2 (0.68) SMARCA2SMARCA4
SCHEMBL9278345 0.79 SMARCA2 (0.65) SMARCA2SMARCA4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025229046-A1 SUBSTITUTED HYDROQUINOLINES FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME MOLIUS SAGLIK TEKNOLOJILERI ANONIM SIRKETI (TR) 2025-11-06 WO disclosed
EP-4644375-A1 SUBSTITUTED HYDROQUINOLINES FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME Molius Saglik Teknolojileri Anonim Sirketi (TR) 2025-11-05 EP disclosed